To define the role of UBIAD1 in melanoma progression and in the biology of real-life melanoma tumors, we evaluated the prognostic potential of its transcriptional levels in the TCGA Skin Cutaneous Melanoma (SKCM) cohort, which represents until now the largest collection of clinico-pathological information of SKCM patients with associated publicly available transcriptomics data (Fig. 1A). The gene discussed is UBIAD1; the disease is cutaneous melanoma.